Patent · US Expired

Synthetic antigens for the detection of antibodies to hepatitis C virus

US6576417B2 · kind B2 · utility

2Cited by

6References

12Claims

0Family size

Assignee

Innogenetics N.V. · BE

Inventors

Robert Deleys · Grimbergen, BE
Dirk Pollet · Schilde, BE
Geert Maertens · Brugge, BE
Hugo Van Heuverswijn · Laarne, BE

Key dates

Filing date	Aug 30, 2001
Grant date	Jun 10, 2003
Priority date	—
Expiry date	Aug 30, 2021

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S530/826
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Peptide sequences are provided which are capable of mimicking proteins encoded by HCV for use as reagents for screening of blood and blood products for prior exposure to HCV. The peptides are at least 5 amino acids long and can be used in various specific assays for the detection of antibodies to HCV, for the detection of HCV antigens, or as immunogens.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.